Survey Study: Financial Impact of Breast Cancer Treatment
Determining the Financial Impact of Breast Cancer Treatment Over a One Year Period for Patients at a Rural Cancer Center
1 other identifier
observational
103
1 country
1
Brief Summary
A survey study to evaluate the financial impact of breast cancer as self-reported by breast cancer patients over a period of 1 year. The study will also look at the health insurance literacy and patient's utilization of support services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedStudy Start
First participant enrolled
September 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2024
CompletedNovember 7, 2024
November 1, 2024
3.8 years
July 31, 2018
November 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in level of self-reported financial burden
Will evaluate the change in Comprehensive Score for Financial Toxicity (COST-FACIT) measurements from baseline to 1 year follow up. This survey consists of 14 questions related to finances.Responses include 5 options with lower scores representing worse outcomes. Scores at 1 year will be compared to baseline scores.
Baseline through 1 year
Secondary Outcomes (2)
Change in level of self-reported health insurance literacy
Baseline through 1 year
Self-reported access and utilization of institutional support services
Baseline through 1 year
Interventions
Patients with breast cancer diagnosis complete questionnaires over 20-30 minutes at baseline and at 3, 6, and 12 months after enrollment.
Eligibility Criteria
Patients seen at rural cancer center with diagnosis of breast cancer or a recurrence of breast cancer within the past 2 years
You may qualify if:
- years or older
- Diagnosed with breast cancer or a recurrence of breast cancer within the past 2 years
- Willing to sign consent
- Able to read and complete surveys in English
You may not qualify if:
- Cancer diagnosis other than breast cancer
- More than 2 years since diagnosis with breast cancer or recurrence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guthrie Medical Group
Sayre, Pennsylvania, 18840, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Perry-Keaty, RN FNP AOCNP
The Guthrie Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2018
First Posted
August 6, 2018
Study Start
September 4, 2018
Primary Completion
June 15, 2022
Study Completion
February 10, 2024
Last Updated
November 7, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share